Insider Trading Activity For Opko Health Inc. (NASDAQ:OPK)
Phillip Md Et Al Frost , CEO of Opko Health Inc. (NASDAQ:OPK) reportedly Bought 50,000 shares of the company’s stock at an average price of 2.57 for a total transaction amount of $128,500.00 SEC Form
Insider Trading History For Opko Health Inc. (NASDAQ:OPK)
Analyst Ratings History For Opko Health Inc. (NASDAQ:OPK)
- On 3/14/2017 Guggenheim Initiated Coverage of rating Buy with a price target of $25.00
- On 8/10/2017 Jefferies Financial Group Reiterated Rating Hold with a price target of $6.80 to $6.50
- On 9/25/2017 LADENBURG THALM/SH SH Reiterated Rating Buy with a price target of $16.00
- On 3/2/2018 JPMorgan Chase & Co. Downgraded rating Neutral to Underweight with a price target of $7.00
- On 8/7/2018 Cantor Fitzgerald Reiterated Rating Buy with a price target of $20.00
- On 2/28/2019 Barrington Research Reiterated Rating Buy with a price target of $5.00
Recent Trading Activity for Opko Health Inc. (NASDAQ:OPK)
Shares of Opko Health Inc. closed the previous trading session at with 2.6 shares trading hands.